2Vial J P, Belloc F, Dumain P, et al. Study of the apoptosis induced in vitro by antitumoral drugs on leukaemic cells. LeukRes, 1997, 21:163-172.
3Hanel M, Friedrichsen K, Hanel A. Mito-flag as salvage therapy for relapsed and refractory acute myeloid leukemia. Onkologie, 2001, 24:356-360.
4Lowenberg B, Suciu S, Archimbaud E, et al. Mitoxantrone versus daunorubicin in induction-consolidation chemotherapy-the value of low-dose cytarabine for maintenance of remission, and an assessment of prognostic factors in acute myeloid leukemia in the elderly: finalreport. European Organization for the Research and Treatment of Cancer and the Dutch-Belgian Hemato-Oncology Cooperative Hovon Group. J Clin Oncol,1998, 16:872-881.
5Hanel M, Friedrichsen K, Hanel A. Mito-flag as salvage therapy for relapsed and refractory acute myeloid leukemia[J]. Onkologie, 2001,24:356-360.
6Vial J P, Belloc F, Dumain P, et al Study of the poptosis induced in vitro by antitumoral drugs on leukaemic cells[J]. Leuk Res, 1998, 22(6):561.
7Kornblau S M, Estey E, Madden T, et al. Study of mitoxantrone plus etoposide with multidrug blockade by SDZ PSC- 833 in relapsed or refractory acute myelogenous leukemia[J]. J Clin Oncol, 1997, 15(5):1796-1802.
8Vial JP,Belloc F, Dumain P,et al. Study of the apoptosis induced in vitro by antitumoral drugs on leukaemic cells. Leuk Res,1998,22:561.
9Hanel M, Friedrichsen K, Hanel A. Mito-flag as salvage therapy for relapsed and refractory acute myeloid leukemia. Onkologie,2001,24:356-360.
10Kornblau SM,Estey E,Madden T,Phase I study of mitoxantrone plus etoposide with multidrug blockade by SDZ PSC-833 in relapsed or refractory acute myelogenous leukemia. J Clin Oncol,1997,15:1796-1802.
